Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

4

SEC Filing Details

Document Details

Form
Filing Date
Dec 19, 2017
Document Date
Dec 15, 2017
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC
Filer
Hoberman Kennet


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved